This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...